Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MD05 vs Beta-TCP in Sinus Floor Augmentation
NCT00520377Phase 2Unknown
- Sponsor
- Scil Technology
- Start
- Jan 2005
- Primary completion
- Dec 2007
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of MD05 in Alveolar bone atrophy (ABL), sponsored by Scil Technology. Status: unknown.
02
Drugs
MD05
03
Conditions
Alveolar bone atrophy (ABL)
Beyond the preview
Go deeper on NCT00520377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520377.